Influence of Methods Used to Establish Sarcopenia Cutoff Values for Skeletal Muscle Measures Using Unenhanced and Contrast‐Enhanced Computed Tomography Images

Abstract

Background:Multiple cutoff values of computed tomography (CT)-based skeletal muscle measures have been proposed, but there is currently no consensus used to identify sarcopenia. We aimed to evaluate the influence of statistical methods used to establish sarcopenia cutoff values and to examine the impact of contrast enhancement on the skeletal muscle measures. Methods: The skeletal muscle area (SMA) and muscle radiation attenuation (MRA) of 316 healthy individuals were measured on unenhanced CT images at the third lumbar vertebra level, and the skeletal muscle index (SMI) was SMA divided by height squared. Possible cutoff values were established using 2 methods: 5 th percentile of individuals aged 20-60 years or mean − 2 × SD of individuals aged 20-50 years. The concordance was assessed using Cohen's κ coefficients and McNemar test. The skeletal muscle parameters on 3 phases from 30 CT examinations were compared. Results: The concordance between the 2 methods was almost perfect (κ coefficients: 0.830-0.849) for low MRA but slight to moderate (κ coefficients: 0.189-0.591) for low SMI, especially in the men (P < 0.01). Compared with the unenhanced images, the mean SMA, SMI, and MRA on the contrast-enhanced images increased by 0.8%-1.7%, 0.8%-1.8%, and 14.8%-21.6% (all P < 0.001), respectively, and only the changes in MRA were clinically significant. Conclusions: The methods for establishing cutoff values and contrast enhancement influence the identification of low SMI and low MRA, respectively. Thus, the definition of sarcopenia should include the standardized method for establishing cutoff values and the phase of CT for analysis. (JPEN J Parenter Enteral Nutr. In this study, we comprehensively evaluated the influence of statistical methods used to establish sarcopenia cutoff values in a healthy population and examined the impact of contrast enhancement on the skeletal muscle measures. Our study highlights the standardized method for establishing cutoff values and the phase of computed tomography for analysis in the definition of sarcopenia. Future research should further validate the proposed sex-specific cutoff values in different patient populations.From the

Prediction of abdominal CT body composition parameters by thoracic measurements as a new approach to detect sarcopenia in a COVID-19 cohort

“…If patients received several CT scans during their hospitalization, the first scan was used. Exclusion criteria were: (a) non-ICU patients to generate a more homogenous collective, and (b) non-contrast-enhanced examinations because the muscle radiodensity attenuation (MRA) would differ between contrast-enhanced and non-contrast-enhanced scans 22 , which biases comparability between patients if no dual-energy CT scans for contrast-agent independent muscle characterization are available 23 . Furthermore, patients were excluded if their CT scans showed (c) artifacts in the paravertebral muscle, e.g., due to osteosynthesis material, (d) did not include the whole abdominal muscle area, or (e) displayed an open abdomen, as all of this could hinder the determination of the skeletal muscle area (SMA) and MRA at L3.…”

Preoperative Body Composition Combined with Tumor Metabolism Analysis by PET/CT Is Associated with Disease‐Free Survival in Patients with NSCLC

“…Based on the previously established gender-specific threshold from healthy adults, low SMI or myopenia is defined as SMI <44.4 cm 2 /m 2 in male and <34.8 cm 2 /m 2 in female, and low SMD or myosteatosis is defined as SMD <34.1 HU in male and <27.2 HU in female. Sarcopenia is defined as the presence of myopenia or myoosteogenesis according to the operational definition of sarcopenia recommended by EWGSOP2 [ 14 ]. According to the obesity standard of Japan Obesity Research Association, VFA is divided into H-VFA (≥100 cm 2 ) and L-VFA (<100 cm 2 ) [ 15 ].…”

Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of 18F-FDG PET/CT in elderly Hodgkin lymphoma patients: a two-centre validation

“…Other authors found an excellent agreement between non-contrast and contrast SMA measurements 29 or a not clinically relevant differences in skeletal muscle mass measurements. 30 In contrast, Feng et al 31 observed a significant difference between the unenhanced and arterial and venous phases. In our analysis, we didn't find any differences using unenhanced and enhanced phases of HDCT; the correlation and the agreement with LDCT is not significantly different and is high in all cases.…”